No Result
View All Result
Thursday, February 25, 2021
Chinese (Simplified)EnglishFrenchGermanItalianJapanesePortugueseRussianSpanish
Near future
  • Home
  • Tech
  • Medicine
  • Society
  • Environment
  • Spazio
  • Transportation
  • Weather
  • concepts
  • H+
Near future
No Result
View All Result

Covid-19 Updates »

May 4, 2020
in Medicine

Neuralgia, experimental treatment of chronic pain in the first human tests

Chinese (Simplified)EnglishFrenchGermanItalianJapanesePortugueseRussianSpanish

Collaborate!

We are open to visions about the future. Submit an article, disclose the results of a search or scientific discoveries, shows points of view on a theme, tells about a change.

CONTACT US
chronic pain neuralgia
Share20Pin1Tweet4SendShare1
Gianluca Ricciodi Gianluca Riccio
2 minutes of reading
tags: painneuralgia

The last

When there was Zoom 60 years ago: the history of the Picturephone

Coca-Cola, the world's largest plastic polluter, tests paper bottles

A Yale team repairs the spinal cord with patient stem cells

The autonomous drone to collect fruit thanks to AI

V90 Villa Edition, camper with terrace on the second floor

A research on chronic pain, lasting an entire decade, works on animals and starts testing on humans. Neuralgia could be cured.

A new paper published in the journal EMBO Molecular Medicine describes the positive results of animal studies given a new experimental peptide designed to inhibit the receptors responsible for chronic neuropathic pain.

The research led by the University of Copenhagen is now moving towards the first human trials for this new type of treatment that can cure neuralgia, a chronic neuropathic pain that arises as a result of damage or malfunction of the nerves of the peripheral nervous system. or of the structures that make up the central nervous system.

"We have developed a new way to treat chronic pain", says the co-author of the new study, Kenneth Lindegaard Madsen. “It is a targeted treatment. That is, it does not affect general neuronal signaling, but only affects the specific nerve that undergoes changes caused by the disease. "

Maybe you are also interested

No Content Available

Some estimates suggest that nearly 10% of the world's population suffers from some sort of neuralgia or chronic neuropathic pain.

Caused by disease or damage to the somatosensory nervous system, this type of pain is notoriously difficult to treat with current medications, including opioids or anticonvulsants, which also cause negative side effects.

Tat-P4- (C5) 2, the formula against neuralgia

The innovation demonstrated in the new study is a peptide called Tat-P4- (C5) 2. Previous experimental treatments for neuropathic pain have worked by attenuating nerve pathways in general, however, side effects were often significant due to the lack of specific treatment targets. The new peptide developed by the research group suggests that it is possible to inhibit only the action of specific receptors responsible for the patient's neuropathic pain.

neuralgia chronic pain Tat-P4
A close up shot of Tat-P4- (C5) 2

A decade of research

“We've been working on it for over 10 years,” says Kenneth Lindegaard Madsen. “We started the process from understanding biology. We invented and designed the compound to then test its functioning in animals. It affects their behavior and removes pain. "

Comment this post on all the social networks where Futuroprossimo.it is present ( Facebook, Instagram, Twitter, Telegram, Linkedin, Vkontakte, Flipboard )

The future of:

Artificial intelligence

OncoHost, artificial intelligence that can “design” oncological therapies

transhumanism

Regenerating therapy, we are now one step away: there are just 5 years left.

Super Gadgets

Retyre, zippered bike tires

Design

Marble Arch Hill, an artificial hill that gives London another point of view

Most read of the week

  • V90 Villa Edition, camper with terrace on the second floor

    V90 Villa Edition, camper with terrace on the second floor

    79 shares
    Share 31 Tweet 20
  • Emrod is about to test remote wireless power transmission

    50 shares
    Share 20 Tweet 13
  • Aging without old age: we can get there very soon

    27 shares
    Share 11 Tweet 7

The last

Vision problems or blindness: three fantastic technologies

Is life expectancy written in our DNA?

It is the hunt for the universal vaccine against all coronaviruses

The US Air Force tests a technology to heal wounds 5 times earlier

The Coral, modular indoor micro algae: wall superfood!

Next article
online events

6 ways to rethink virtual events in the coronavirus era

Futuroprossimo.it is an Italian resource of futurology opened since 2006: every day news about the near future. Scientific discoveries, medical research, prototypes, concepts and predictions about the future for free.

Tag

Environment Architecture Communication concepts Advice Energy Events Gadgets The future of yesterday The newspaper of tomorrow Medicine Military Weather Robotica Society Spazio Technology transhumanism Transportation Video

Categories

The author

Gianluca Riccio, copywriter and journalist - Born in 1975, he is the creative director of an advertising agency, he is affiliated with the Italian Institute for the Future, World Future Society and H +, Network of Italian Transhumanists.

Collaborate! Are you interested in writing a post on Futuroprossimo? Click here for contacts.

Home / Author / IDEA / archive / Promo on FP

© 2020 Futuroprossimo - Tailored by Be Here

© 2020 Futuroprossimo - Tailored by Be Here

  • Home
  • Contact
  • archive
  • Technology
  • Medicine
  • Transportation
  • Weather
  • Society
  • Environment
  • transhumanism

© 2019 Futuroprossimo - Tailored by To be here

This site uses cookies. By continuing to read it, you consent to their use.